Navigation Links
Bed bugs are not repelled by commercial ultrasonic frequency devices
Date:12/10/2012

Alternative means of controlling urban insect pests by using ultrasonic frequencies are available and marketed to the public. However, few of these devices have been demonstrated as being effective in repelling insect pests such as mosquitoes, cockroaches, or ants. Despite the lack of evidence for the efficacy of such devices, they continue to be sold and new versions targeting bed bugs are readily available.

However, according to a soon-to-be-published article in the Journal of Economic Entomology, commercial devices that produce ultrasound frequencies are NOT promising tools for repelling bed bugs. In "Efficacy of Commercially Available Ultrasonic Pest Repellent Devices to Affect Behavior of Bed Bugs (Hemiptera: Cimicidae)," , authors K. M. Yturralde and R. W. Hofstetter report the results of their tests of four commercially available electronic pest repellent devices designed to repel insect and mammalian pests by using sound.

The devices, which were purchased online, were used according to manufacturers' instructions. A sound arena was created for each ultrasonic device, in addition to a control arena which featured no sound. However, the authors found that there were no significant differences in the number of bed bugs observed in the control (no sound) and sound arenas, and that bed bugs were neither deterred nor attracted to the arena with the sound device.

The authors conclude that the ultrasonic devices may not have deterred or attracted bed bugs because they may not have produced the right combination of frequencies. Bed bugs are commonly exposed to frequencies made by their host species (humans) and by appliances and machines found in homes. Therefore, it may be possible that bed bugs also would exploit sounds made by their human hosts, such as breathing or snoring. Future studies of bed bug bioacoustics may be served well by using low-frequency sounds produced by host species.


'/>"/>
Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America
Source:Eurekalert

Page: 1

Related biology news :

1. NIST focuses on testing standards to support lab on a chip commercialization
2. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
7. Simplifying heart surgery with stretchable electronics devices
8. Medical devices powered by the ear itself
9. Tattoo-like devices for wireless pregnancy monitoring
10. NJIT professor awarded patent today for new desalination devices, more
11. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: